Surrozen, Inc./DE Increase (Decrease) in Prepaid Expense
Surrozen, Inc./DE (SRZN) reported Increase (Decrease) in Prepaid Expense of $790.34 thousand for the 4-month period ending 2020-12-31, per its 10-K/A filed 2021-05-14.
Discontinued › Cash Flow
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2021-05-14
- 2020-12-31: Increase (Decrease) in Prepaid Expense 4 month $790.34K.
| Period end | Increase (Decrease) in Prepaid Expense 4 month |
|---|---|
| 2020-12-31 | $790.34K 10-K/A · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |